• About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Sun exposure and MS: effects beyond vitamin D

May 26, 2020  

Treatment optimization in MS – new Canadian recommendations

May 15, 2020  

Siponimod – new data in SPMS

April 23, 2020  

FDA approves ozanimod in MS

April 16, 2020  

MS and coronavirus have a long history

April 9, 2020  

MS 2020 – the view from a decade ago

March 18, 2020  

Natalizumab use in late pregnancy

February 19, 2020  

New drug approvals in 2020

February 5, 2020  

MS prognosis – 30-year follow-up

January 22, 2020  

Sequencing MS therapies – a changing landscape

December 17, 2019  
Previous
1
2
3
4
5
Next

Browse by Topic

MS (268)
AD (81)
PD (77)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
COVID-19 (16)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (10)
ECTRIMS 2019 (10)
ECTRIMS 2013 (9)
AAN 2014 (9)
MS SEQUENCING (9)
AAN 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (7)
ECTRIMS 2016 (6)
CHARCOT 2013 (6)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2017 (4)
EAN 2015 (4)
BPD (4)
NeuroSound (4)
AAN 2018 (3)
PAIN (3)
ENS 2013 (3)
AAN 2020 (3)
APA 2014 (2)
EAN 2020 (2)
SPECIAL REPORT (2)
SLEEP (2)
NEW DRUGS (2)
AAN 2016 (2)
ADDICTION (1)
EAN 2019 (1)
LUMBAR PUNCTURE (1)
CONCUSSION (1)
CIDP (1)
Dravet syndrome (1)
hATTR (1)
ALS (1)
SEIZURE (1)
INSOMNIA (1)
WEST NILE (1)
LGS (1)
APA 2016 (1)
EAN 2016 (1)
GUIDELINES (1)
TSC (1)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • Multiple sclerosis 2021 – a look ahead posted on January 13, 2021
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
  • Ozanimod vs. fingolimod: is there a difference? posted on November 13, 2020
Copyright 2021 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions